🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liver Transplantation

Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant. NCT06327308Phase 14 sites📍 Besançon📍 Dijon📍 Nancy Centre Hospitalier Universitaire de Besancon · Tests: MRI, Blood sampling LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA) NCT06125769NA1 site📍 Padova Azienda Sanitaria Ospedaliera · Tests: Liver transplantation Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool NCT06088758NA1 site📍 Boston Massachusetts General Hospital · Tests: Normothermic machine perfusion (NMP) of steatotic liver FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis NCT06801665Phase 21 site📍 Changzhou Hua Jiang · Tests: FMT+QL1706+Bevacizumab+XELOX Preoperative Prehabilitation in Patients Planned for Liver Transplantation NCT06808945NA1 site📍 Rotterdam Erasmus Medical Center · Tests: Prehabilitation program TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases NCT07607873NA1 site📍 Milan Niguarda Hospital · Tests: Liver Transplantation, Liver Resection plus Ablation Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy. NCT07611721NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: Continuous glucose monitor Defibrotide Dose-escalation for SOS Post-HSCT NCT05987124Phase 21 site📍 Vallhala New York Medical College · Tests: Defibrotide Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection NCT06698146n/a1 site📍 Chicago Northwestern University Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time NCT06874296NA10 sites📍 Hamburg📍 Aachen📍 Bonn Charite University, Berlin, Germany · Tests: Quality Assessment with Normothermic Machine Perfusion (NMP) Expanding HOPE Liver NCT07778459n/a2 sites📍 Baltimore📍 New York National Institute of Allergy and Infectious Diseases (NIAI… A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. NCT05686759Phase 38 sites📍 Goyang-si📍 Suwon📍 Seoul GC Biopharma Corp · Tests: Undiluted I.V.-Hepabig inj(GC5103), Diluted I.V.-Hepabig inj(GC5103) EBD RCT Trial in Living Donor Liver Transplantation NCT04622540NA1 site📍 Seoul Seoul National University Hospital · Tests: External biliary drainage Cabozantinib to Treat Recurrent Liver Cancer Post Transplant NCT04204850Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Cabozantinib Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) NCT07428538Phase 392 sites📍 Birmingham📍 Mobile📍 Phoenix Bausch Health Americas, Inc. · Tests: Larsucosterol, Placebo CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) NCT06619561Phase 226 sites📍 Duarte📍 Los Angeles📍 Orange Deciphera Pharmaceuticals, LLC · Tests: Vimseltinib Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients NCT05793203n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial) NCT04556214NA1 site📍 Oslo Oslo University Hospital · Tests: Liver Transplant Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation. NCT05761483n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: ERCP Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures NCT06716541NA1 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: ERCP implantation of a biodegradable stent, ERCP implantation of plastic stents Adverse Outcomes and Mortality in Liver Transplant NCT05477277NA1 site📍 Phoenix Mayo Clinic · Tests: MAsS Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma NCT04993131NA1 site📍 Oslo Oslo University Hospital · Tests: Liver transplant US National OCS Liver Perfusion (OLP) Registry NCT05940857n/a22 sites📍 Birmingham📍 Phoenix📍 La Jolla TransMedics · Tests: OCS Liver Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe NCT07585890n/a37 sites📍 Innsbruck📍 Vienna📍 Brussels University Medical Center Groningen · Tests: Endischemic hypothermic oxygenated machine perfusion (any device), Endischemic (back-to-base) normothermic machine perf… Design and Implementation of the Pediatric Liver Transplantation Biobank NCT04477967n/a1 site📍 Chongqing Children's Hospital of Chongqing Medical University · Tests: No intervention Hepatic Histopathology in Urea Cycle Disorders NCT04908319n/a2 sites📍 Washington D.C.📍 Houston Baylor College of Medicine Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial NCT07157631NA1 site📍 Shanghai RenJi Hospital · Tests: tranexamic acid, 0.9 % saline Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus NCT06060392NA1 site📍 Gurgaon Medanta, The Medicity, India · Tests: Semaglutide Pill Predictive Factors for Massive Transfusion During Liver Transplantation NCT05763446n/a2 sites📍 Rome📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy